BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange BioHarvest Sciences stocks are traded under the ticker 8MV.STU.
What is BioHarvest Sciences revenue for the last year?▼
BioHarvest Sciences revenue for the last year amounts to 29.94M EUR.
What is BioHarvest Sciences net income for the last year?▼
8MV.STU net income for the last year is -9.64M EUR.
How many employees does BioHarvest Sciences have?▼
As of July 15, 2026, the company has 89 employees.
In which sector is BioHarvest Sciences located?▼
BioHarvest Sciences operates in the Essentials sector.
When did BioHarvest Sciences complete a stock split?▼
BioHarvest Sciences has not had any recent stock splits.
Where is BioHarvest Sciences headquartered?▼
BioHarvest Sciences is headquartered in Vancouver, Canada.